This inventor holds 1 USPTO granted patent. Top assignee: University of Rochester. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Mind of Alexander Stanley Thrane
Introduction
Alexander Stanley Thrane is a notable inventor based in Oslo, Norway. He is recognized for his contribution to the field of neuroscience through a significant patent that addresses brain impairment caused by ammonia neurotoxicity.
Latest Patents
Thrane holds one patent that presents a pioneering method for treating and preventing brain impairment in subjects susceptible to elevated plasma ammonia levels. His invention revolves around the administration of a Na+-K+-2Cl- cotransporter isoform 1 (NKCC1) inhibitor. This method is designed to ameliorate conditions that lead to ammonia neurotoxicity by ensuring the proper functioning of astrocytes, integral cells in the brain responsible for potassium buffering. The innovative treatment method not only targets the inhibition of potassium accumulation around astrocytes but also aims to maintain their essential functions.
Career Highlights
Currently, Thrane is affiliated with the University of Rochester, where he applies his research skills and innovations. His work is instrumental in advancing our understanding of ammonia's effects on brain health.
Collaborations
Thrane collaborates with esteemed colleagues Maiken Nedergaard and Vinita Rangroo Thrane. Together, they contribute to groundbreaking research that further investigates the role of astrocytes in brain function and potential therapeutic interventions.
Conclusion
Alexander Stanley Thrane exemplifies the spirit of innovation within the scientific community. His research not only showcases his dedication to improving neurological health but also highlights the collaborative efforts essential in addressing complex medical challenges. Through his work, Thrane paves the way for future advancements in the treatment of brain impairment.